Pioneer Research Solutions, Inc.

04/14/2026

Do you have IBS with diarrhea or mixed bowel habits?
You may qualify for a clinical research study.
We are looking for adults 18 to 80 years old who have been diagnosed with:
IBS-D — Irritable Bowel Syndrome with Diarrhea
IBS-M — Irritable Bowel Syndrome with Mixed Bowel Habits
This study is evaluating camlipixant, an investigational medication sponsored by GSK. To qualify, participants may need to meet study screening criteria, including Rome IV criteria, and have moderate to severe IBS symptoms.
If you or someone you know experiences frequent diarrhea, urgent bowel movements, abdominal discomfort, bloating, or mixed bowel habits, this study ma


















be a good fit. IBS-C and IBS-U are not the target diagnoses for this trial.
Interested? Contact us to learn more and see if you may qualify.
Pioneer Research Solutions Inc.
10700 Stancliff Rd
Houston, TX 77099
Call or Text: 713-903-9674
Email: saleem@pioneerresearchsolutions.com

04/10/2026

DO YOU USE AN INHALER?
Have you been diagnosed with asthma?
Be part of our Asthma Research Study
Learn more about asthma and breathing in a real-world research study.
*Free asthma study-related tests may include:*
*FeNO breath test*
*Spirometry (lung function test)*
*Blood work*
Asthma questionnaires
No experimental medication
Regular asthma care continues
*Compensation: Get $138*
Pioneer Research Solutions Inc.
10700 Stancliff Rd, Houston, TX 77099
Call or Text: 713-903-9674
saleem@pioneerresearchsolutions.com

04/09/2026

Thrilled to share this recognition for the Pioneer Research Solutions Inc. Study Team as Top Agents for the ENLIGHTEN-Fibrosis program.
The ENLIGHTEN-Fibrosis Study is a Phase 3 research study for adults with MASH (fatty liver with inflammation) and liver fibrosis F2–F3. The study is evaluating pegozafermin, an investigational treatment that may help improve liver scarring and overall liver health. Qualified participants may undergo screening tests to determine eligibility.
At Pioneer Research Solutions, we remain committed to advancing clinical research, expanding access to innovative studies, and helping connect patients with potential new treatment options.
Grateful to our dedicated team for their hard work, commitment, and passion for patient care and research excellence.

03/20/2026

Eid Mubarak from Pioneer Research Solutions Inc. 🌙
“Allah intends ease for you, not hardship.” — Quran 2:185 �
Quran.com
Today is a reminder of gratitude, faith, service, and hope.
May this Eid bring peace to every heart, blessings to every home, and success to every good intention.

Keep faith. Spread kindness. Serve humanity. Shine with purpose.
— Saleem Sajwani
Pioneer Research Solutions Inc.
713-903-9674

03/09/2026

02/18/2026

🌙✨ Ramadan Mubarak from Pioneer Research Solutions Inc. ✨🌙
يَا أَيُّهَا الَّذِينَ آمَنُوا كُتِبَ عَلَيْكُمُ الصِّيَامُ كَمَا كُتِبَ عَلَى الَّذِينَ مِن قَبْلِكُمْ لَعَلَّكُمْ تَتَّقُونَ
“O you who have believed, fasting has been prescribed upon you as it was prescribed upon those before you that you may become righteous.” (Qur’an 2:183)
This blessed month reminds us of patience, compassion, discipline, and gratitude.
At Pioneer Research Solutions Inc, we are committed to serving our community with care, integrity, and excellence.
May this Ramadan bring peace to your heart, health to your body, and blessings to your home. 🤲✨

01/23/2026

🎯 Clinical Trial Opportunity: IBS-C in Children
We’re looking for children ages 6–18 years with IBS-C (Irritable Bowel Syndrome with Constipation) to join a 4-week research study!
What is this study about?
✅ Testing different doses of a new medication for IBS-C
✅ Relieve constipation and improve bowel habits safely
Who can join?
✔️ Children 6 to 18 years old
✔️ Diagnosed with IBS-C (constipation-predominant)
✔️ Able to follow study instructions and diary entries
Who cannot join?
❌ Children with serious gastrointestinal conditions other than IBS-C
❌ Children with allergies to study medication
❌ Children who cannot comply with study visits or procedures
What will happen if my child joins?
✅ Receive study medication at different doses
✅ Parents track bowel habits and symptoms in a diary
✅ Regular clinic visits and safety checks
✅ Doctors closely monitor health and side effects
Benefits of Joining
⭐ Access to a potentially helpful new medication
⭐ Contribute to medical research to help other children
⭐ Receive close medical monitoring during the study
Contact Information
📞 Call: Saleem Sajwani – Business Development Associate
📱 Phone: (713) 903-9674
✉️ Email: saleem@pioneerresearchsolutions.com

01/23/2026

❤️🩸 What is Severe High Triglycerides — and Why Should You Care?
Triglycerides are a type of fat in your blood.
Your body needs some fat for energy, but too much can be dangerous.
📊 Blood Levels: • Normal: Below 150
• High: 200 – 499
• 🚨 Severe High Triglycerides: 500 or higher
⚠️ Why is this serious?
Very high triglycerides can cause:
❗ Pancreatitis (dangerous pancreas inflammation)
❗ Higher risk of: • Heart attack
• Stroke
• Liver disease
Symptoms may include: • Stomach pain
• Nausea or vomiting
• Fatigue
• Or no symptoms at all until a serious problem happens.
🔬 About This Clinical Study
This study is for adults with very high triglycerides.
🎯 Purpose of the study: To test a new treatment and see: • How well it lowers triglyceride levels
• How safe it is for patients
👥 Who may qualify?
Adults who: ✔️ Have triglycerides 500 or higher
✔️ May have: • Diabetes
• Metabolic syndrome
• Fatty liver disease
✔️ Are at risk for pancreatitis or heart disease
If you or someone you know has very high triglycerides, this study may be an opportunity to receive expert care and help advance medical research.
📞 Contact: Saleem Sajwani
📱 713-903-9674
📧 saleem@pioneerresearchsolutions.com

01/23/2026

🦶💥 What is Gout — and How Can New Research Help?
Gout is a painful type of arthritis caused by high uric acid in the blood.
When uric acid builds up, it forms sharp crystals in the joints, leading to:
✔️ Sudden, severe joint pain (often in the big toe)
✔️ Swelling, redness, and warmth
✔️ Difficulty walking or moving the joint
If not controlled, gout can cause permanent joint damage.
🔬 About This Clinical Study
This is a Phase 3, Randomized, Double-Blind, Multicenter Study — the most important stage of testing a new medicine.
What does that mean?
• Phase 3: Large study to confirm safety and effectiveness
• Randomized: You’re assigned by chance to one treatment
• Double-Blind: Neither you nor the doctor knows which medicine you get
• Multicenter: Study is happening at many locations
💊 What is the study testing?
Comparing: 👉 Dotinurad (new gout medicine)
vs.
👉 Allopurinol (standard gout medicine)
🎯 Goal: To see which medicine lowers uric acid better and is safe for adults with gout.
If you or someone you know has gout and high uric acid, you may qualify to participate and help advance medical research.
📞 Contact: Saleem Sajwani
📱 713-903-9674
📧 saleem@pioneerresearchsolutions.com